Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: FDA warns public about reprocessed catheter recalls

News You Need to Know Today
News Alert: FDA warns public about reprocessed catheter recalls
Friday, March 6, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA shares details about reprocessed catheter recall

Back in February, the FDA expanded a recall of several reprocessed EP and ultrasound catheters due to a risk of contamination. The agency is now sharing additional information with the public.

READ MORE >
FDA issues recall of imaging systems
Share on Twitter Share on Facebook Share on Linkedin

FDA shares details about reprocessed catheter recall

Share on Twitter Share on Facebook Share on Linkedin
FDA issues recall of imaging systems
Back in February, the FDA expanded a recall of several reprocessed EP and ultrasound catheters due to a risk of contamination. The agency is now sharing additional information with the public.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Bayer's big news | Predicting heart issues in COVID-19 patients | Beloved cardiologist dies at 86
Interventional & Surgery: Prasugrel & PCI | A key approval for Medtronic
A new MRI technique | Embrace plant-based foods, limit most meats to avoid heart disease
Week in Review: Blood tests recalled | TAVR still comparable to surgery after 8 years | Empagliflozin & HFpEF
COVID-19: Heart issues can last for months | A big FDA announcement | AI-powered detection
TAVR vs. surgery after 8 years | Omega-3 fatty acids | COVID-related heart issues often last for months
Empagliflozin for HFpEF | AI predicts diabetes risk | Congenital heart disease & stroke

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …270
    • Page 271
    • Page 272
    • Page 273
    • Current page 274
    • Page 275
    • Page 276
    • Page 277
    • Page 278 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup